Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 249

1.

The application of aptamers in cancer research: an up-to-date review.

Hu M, Zhang K.

Future Oncol. 2013 Mar;9(3):369-76. doi: 10.2217/fon.12.201. Review.

PMID:
23469972
2.

Nucleic acid aptamers targeting cell-surface proteins.

Dua P, Kim S, Lee DK.

Methods. 2011 Jun;54(2):215-25. doi: 10.1016/j.ymeth.2011.02.002. Epub 2011 Feb 12. Review.

PMID:
21300154
3.

Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.

Li X, Zhao Q, Qiu L.

J Control Release. 2013 Oct 28;171(2):152-62. doi: 10.1016/j.jconrel.2013.06.006. Epub 2013 Jun 15. Review.

PMID:
23777885
4.

Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.

Zhu H, Li J, Zhang XB, Ye M, Tan W.

ChemMedChem. 2015 Jan;10(1):39-45. doi: 10.1002/cmdc.201402312. Epub 2014 Oct 2. Review.

PMID:
25277749
5.

Aptamers: a promising tool for cancer imaging, diagnosis, and therapy.

Liu K, Lin B, Lan X.

J Cell Biochem. 2013 Feb;114(2):250-5. doi: 10.1002/jcb.24373.

PMID:
22949372
6.

Applications of aptamers in cancer cell biology.

Phillips JA, Lopez-Colon D, Zhu Z, Xu Y, Tan W.

Anal Chim Acta. 2008 Jul 28;621(2):101-8. doi: 10.1016/j.aca.2008.05.031. Epub 2008 May 21. Review.

PMID:
18573375
7.

Application of aptamers for targeted therapeutics.

Ray P, Viles KD, Soule EE, Woodruff RS.

Arch Immunol Ther Exp (Warsz). 2013 Aug;61(4):255-71. doi: 10.1007/s00005-013-0227-0. Epub 2013 Apr 7. Review.

PMID:
23563807
8.

Aptamer-modified nanoparticles and their use in cancer diagnostics and treatment.

Reinemann C, Strehlitz B.

Swiss Med Wkly. 2014 Jan 6;144:w13908. doi: 10.4414/smw.2014.13908. Review.

9.

Aptamers: versatile probes for flow cytometry.

Meyer M, Scheper T, Walter JG.

Appl Microbiol Biotechnol. 2013 Aug;97(16):7097-109. doi: 10.1007/s00253-013-5070-z. Epub 2013 Jul 10. Review.

PMID:
23838792
10.

DNA and RNA aptamers: from tools for basic research towards therapeutic applications.

Ulrich H, Trujillo CA, Nery AA, Alves JM, Majumder P, Resende RR, Martins AH.

Comb Chem High Throughput Screen. 2006 Sep;9(8):619-32. Review.

PMID:
17017882
11.

Nanotechnology and aptamers: applications in drug delivery.

Levy-Nissenbaum E, Radovic-Moreno AF, Wang AZ, Langer R, Farokhzad OC.

Trends Biotechnol. 2008 Aug;26(8):442-9. doi: 10.1016/j.tibtech.2008.04.006. Epub 2008 Jun 19. Review.

PMID:
18571753
12.

Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.

Liao J, Liu B, Liu J, Zhang J, Chen K, Liu H.

Expert Opin Drug Deliv. 2015 Mar;12(3):493-506. doi: 10.1517/17425247.2015.966681. Epub 2014 Nov 28. Review.

PMID:
25430795
13.

Aptamers: multifunctional molecules for biomedical research.

Banerjee J, Nilsen-Hamilton M.

J Mol Med (Berl). 2013 Dec;91(12):1333-42. doi: 10.1007/s00109-013-1085-2. Epub 2013 Sep 18. Review.

PMID:
24045702
14.

Aptamer applications for targeted cancer therapy.

Barbas AS, Mi J, Clary BM, White RR.

Future Oncol. 2010 Jul;6(7):1117-26. doi: 10.2217/fon.10.67. Review.

PMID:
20624124
15.

Aptamer-drug conjugation for targeted tumor cell therapy.

Donovan MJ, Meng L, Chen T, Zhang Y, Sefah K, Tan W.

Methods Mol Biol. 2011;764:141-52. doi: 10.1007/978-1-61779-188-8_9.

PMID:
21748638
16.

Complex target SELEX.

Shamah SM, Healy JM, Cload ST.

Acc Chem Res. 2008 Jan;41(1):130-8. doi: 10.1021/ar700142z. Review.

PMID:
18193823
17.

Aptamers and SELEX in Chemistry & Biology.

Famulok M, Mayer G.

Chem Biol. 2014 Sep 18;21(9):1055-8. doi: 10.1016/j.chembiol.2014.08.003.

18.

Chimeric aptamers in cancer cell-targeted drug delivery.

Kanwar JR, Roy K, Kanwar RK.

Crit Rev Biochem Mol Biol. 2011 Dec;46(6):459-77. doi: 10.3109/10409238.2011.614592. Epub 2011 Sep 28. Review.

19.

Nanoparticle-aptamer conjugates for cancer cell targeting and detection.

Estévez MC, Huang YF, Kang H, O'Donoghue MB, Bamrungsap S, Yan J, Chen X, Tan W.

Methods Mol Biol. 2010;624:235-48. doi: 10.1007/978-1-60761-609-2_16.

PMID:
20217600
20.

SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.

Stoltenburg R, Reinemann C, Strehlitz B.

Biomol Eng. 2007 Oct;24(4):381-403. Epub 2007 Jun 16. Review.

PMID:
17627883

Supplemental Content

Support Center